SOPHiA GENETICS is excited to be a part of the Association for Molecular Pathology (AMP) 2024 Europe Congress held in Madrid, Spain from June 24th – 26th.
You will have the chance to chat with our experts at booth #12 and demo the universal SOPHiA DDM™ Platform.
Join us for our talk “From DNA to insights: Uncovering the overlooked with innovative NGS technology for MRD assessment” presented by Jose Maria Belloso, PhD, Global Product Manager – HemOnc, SOPHiA GENETICS and Silvia Salmoiraghi, PhD, Ultra-specialist Laboratory of Clinical Pathology-Hematology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
During our presentation, the following topics will be discussed:
- Optimizing Acute Myeloid Leukemia monitoring: A novel NGS application for Measurable Residual Disease (MRD) assessment
- Staying ahead of disease response with the analytical capabilities of the SOPHiA DDM™ Platform
Date: June 25th, 2024
Time: 9:45 – 10:45
While on site, make sure to check out our poster:
Fine-Tuning Sensitivity: Establishing an Optimal Framework for Measurable Residual Disease Detection in Acute Myeloid Leukemia at 0.01%
R. Kempfer, J. Bieler, Y. Liu, A. Willig, S. Kubik, Z. Xu
We look forward to seeing you there!
